Liz Barrett

As Barrett steps in as CEO, UroGen reports 57% complete response rate for urothelial cancer therapy
BioCentury
Tue, 01/8/19 - 11:44 pm
Urogen
UGN-101
MitoGel
urothelial cancer
Liz Barrett
Why did Liz Barrett turn her back on a top job at Novartis in exchange for the helm of a biotech you never heard of?
Endpoints
Thu, 01/3/19 - 04:10 pm
Liz Barrett
Novartis
Urogen
Novartis oncology CEO quits after less than a year
Pharmaforum
Thu, 12/20/18 - 10:07 am
Novartis
oncology
Susanne Schaffert
Liz Barrett